Australia markets close in 2 hours 20 minutes

Pliant Therapeutics Inc (9PT.F)

Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
11.20+0.10 (+0.90%)
At close: 03:29PM CEST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
248
1,580
9,685
7,572
41,817
-
Operating expenses
Research development
135,670
127,797
96,936
77,549
66,193
-
Selling general and administrative
59,020
57,928
39,949
27,558
17,269
-
Total operating expenses
194,690
185,725
136,885
105,107
83,462
-
Operating income or loss
-194,442
-184,145
-127,200
-97,535
-41,645
-
Interest expense
1,401
1,267
791
0
-
-
Total other income/expenses net
-
-
-
-
-366
-216
Income before tax
-170,743
-161,336
-123,321
-97,263
-41,533
-
Income from continuing operations
-170,743
-161,336
-123,321
-97,263
-41,533
-
Net income
-170,743
-161,336
-123,321
-97,263
-41,533
-
Net income available to common shareholders
-170,743
-161,336
-123,321
-97,263
-41,533
-
Basic EPS
-2.78
-2.75
-2.94
-2.71
-1.95
-
Diluted EPS
-2.78
-2.75
-2.94
-2.71
-1.95
-
Basic average shares
55,954
58,719
42,016
35,846
21,344
-
Diluted average shares
55,954
58,719
42,016
35,846
21,344
-